e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Complex respiratory infections in clinical practice
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled antibiotic treatment reduces the frequency of infective exacerbations in bronchiectasis: a single center, real life study
S. Nazzal (Haifa , Israel), Y. Adir (Haifa , Israel), R. Cohen (Haifa , Israel), N. Stein (Haifa , Israel), M. Shteinberg (Haifa , Israel)
Source:
International Congress 2019 – Complex respiratory infections in clinical practice
Session:
Complex respiratory infections in clinical practice
Session type:
Thematic Poster
Number:
4576
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Nazzal (Haifa , Israel), Y. Adir (Haifa , Israel), R. Cohen (Haifa , Israel), N. Stein (Haifa , Israel), M. Shteinberg (Haifa , Israel). Inhaled antibiotic treatment reduces the frequency of infective exacerbations in bronchiectasis: a single center, real life study. 4576
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Telithromycin for acute exacerbations of asthma: pulmonary function data from the TELICAST study
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005
Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021
Does long-term macrolide treatment reduce asthma exacerbations? An individual patient data meta-analysis
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Inhaled maintenance therapy and risk of first or subsequent emergency department visit/hospitalization in patients with COPD
Source: Annual Congress 2006 - COPD therapy
Year: 2006
COPD: antibiotic strategy in infectious exacerbations
Source: Eur Respir J 2001; 18: Suppl. 33, 137s
Year: 2001
Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis
Source: Eur Respir J, 58 (6) 2101416; 10.1183/13993003.01416-2021
Year: 2021
Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD
Source: Eur Respir J 2009; 33: 282-288
Year: 2009
Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis
Source: Eur Respir J, 54 (5) 1901381; 10.1183/13993003.01381-2019
Year: 2019
Evaluation of contribution of high frequency chest wall oscillation treatment to medical treatment in patients with acute exacerbations of COPD
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011
Systematic review: Does antibiotic treatment duration affect the outcomes of asthma and COPD exacerbations?
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017
The role of inhaled antibiotics in bronchial infection
Source: Eur Respir Monogr 2013; 60: 120-126
Year: 2013
Why short-term antibiotic use in AECB may influence long-term outcomes
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
The effect on mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A focus on the frequent exacerbator phenotype
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014
Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapy
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019
Year: 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept